Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641489-26-000015
Filing Date
2026-04-28
Accepted
2026-04-28 16:21:28
Documents
24
Period of Report
2026-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A vtvt-20260428.htm   iXBRL DEF 14A 465330
6 GRAPHIC vtvt-20260428_g1.jpg GRAPHIC 684980
7 GRAPHIC vtvt-20260428_g10.jpg GRAPHIC 229294
8 GRAPHIC vtvt-20260428_g2.jpg GRAPHIC 120640
9 GRAPHIC vtvt-20260428_g3.jpg GRAPHIC 163380
10 GRAPHIC vtvt-20260428_g4.jpg GRAPHIC 119019
11 GRAPHIC vtvt-20260428_g5.jpg GRAPHIC 127279
12 GRAPHIC vtvt-20260428_g6.jpg GRAPHIC 117063
13 GRAPHIC vtvt-20260428_g7.jpg GRAPHIC 494934
14 GRAPHIC vtvt-20260428_g8.jpg GRAPHIC 398630
15 vtvt-20260428_g9.jpg GRAPHIC 451601
  Complete submission text file 0001641489-26-000015.txt   7703192

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20260428.xsd EX-101.SCH 2261
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20260428_def.xml EX-101.DEF 2226
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20260428_lab.xml EX-101.LAB 2351
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20260428_pre.xml EX-101.PRE 1316
27 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20260428_htm.xml XML 169952
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37524 | Film No.: 26908188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)